Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (351-360 of 741) with videos related to

Pageof 75
Sort By:
Archives of Neurology|January 11, 2012
Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid DepositionDenise Head, Julie M Bugg, Alison M Goate, et al.
The Journal of Experimental Medicine|October 15, 2020
Immigration in scienceJean-Laurent Casanova, David M Holtzman, Susan M Kaech, et al.
Neurobiology of Disease|June 2, 2005
Role of caspase-3 in ethanol-induced developmental neurodegenerationChainllie Young, Kevin A Roth, Barbara J Klocke, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjectsKaushik Ghosal, Michael Haag, Philip B Verghese, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Role of biomarkers in studies of presymptomatic Alzheimer's diseaseJohn C Morris, A Kimberly, K Quaid, et al.
Molecular Neurodegeneration|April 20, 2012
Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labelingJacob M Basak, Jungsu Kim, Yuriy Pyatkivskyy, et al.
Neurobiology of Aging|November 13, 2013
Functional connectivity and graph theory in preclinical Alzheimer's diseaseMatthew R Brier, Jewell B Thomas, Anne M Fagan, et al.
STAR Protocols|June 8, 2023
Standardized immunoprecipitation protocol for efficient isolation of native apolipoprotein E particles utilizing HJ15.4 monoclonal antibodyJustin O'Leary, Ana-Caroline Raulin, Zonghua Li, et al.
Molecular Neurodegeneration|October 24, 2019
Targeting tauopathy with engineered tau-degrading intrabodiesGilbert Gallardo, Connie H Wong, Sara M Ricardez, et al.
Journal of Biochemistry|November 6, 2002
Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related proteinMasaaki Narita, David M Holtzman, Anne M Fagan, et al.
Pageof 75

Showing results (351-360 of 741) with videos related to

Sort By:
Pageof 75
Archives of Neurology|January 11, 2012
Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid DepositionDenise Head, Julie M Bugg, Alison M Goate, et al.
The Journal of Experimental Medicine|October 15, 2020
Immigration in scienceJean-Laurent Casanova, David M Holtzman, Susan M Kaech, et al.
Neurobiology of Disease|June 2, 2005
Role of caspase-3 in ethanol-induced developmental neurodegenerationChainllie Young, Kevin A Roth, Barbara J Klocke, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjectsKaushik Ghosal, Michael Haag, Philip B Verghese, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Role of biomarkers in studies of presymptomatic Alzheimer's diseaseJohn C Morris, A Kimberly, K Quaid, et al.
Molecular Neurodegeneration|April 20, 2012
Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labelingJacob M Basak, Jungsu Kim, Yuriy Pyatkivskyy, et al.
Neurobiology of Aging|November 13, 2013
Functional connectivity and graph theory in preclinical Alzheimer's diseaseMatthew R Brier, Jewell B Thomas, Anne M Fagan, et al.
STAR Protocols|June 8, 2023
Standardized immunoprecipitation protocol for efficient isolation of native apolipoprotein E particles utilizing HJ15.4 monoclonal antibodyJustin O'Leary, Ana-Caroline Raulin, Zonghua Li, et al.
Molecular Neurodegeneration|October 24, 2019
Targeting tauopathy with engineered tau-degrading intrabodiesGilbert Gallardo, Connie H Wong, Sara M Ricardez, et al.
Journal of Biochemistry|November 6, 2002
Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related proteinMasaaki Narita, David M Holtzman, Anne M Fagan, et al.
Pageof 75